-
Signature
-
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
-
Issuer symbol
-
RNA
-
Transactions as of
-
07 May 2024
-
Net transactions value
-
-$680,330
-
Form type
-
4
-
Filing time
-
07 May 2024, 21:52:58 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RNA |
Common Stock |
Options Exercise |
$34,720 |
+28,000 |
+25% |
$1.24* |
140,117 |
07 May 2024 |
Direct |
F1, F2 |
| transaction |
RNA |
Common Stock |
Sale |
$715,050 |
-28,000 |
-20% |
$25.54 |
112,117 |
07 May 2024 |
Direct |
F1, F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-28,000 |
-3.2% |
$0.000000 |
845,015 |
07 May 2024 |
Common Stock |
28,000 |
$1.24 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: